Article Figures & Data
Tables
Characteristic n Percentage Age (years) 32–46 5 12 46–65 27 63 65–75 11 26 Male 28 65 Race/ethnicity White 33 77 Black 3 7 Hispanic 3 7 Asian 3 7 Arabic 1 2 Type II diabetes 34 79 Comorbidities requiring hospitalization Coronary disease 9 21 Stroke 4 9 Foot ulcer 2 5 Heart failure 2 5 Diabetes medications Insulin 20 46 Metformin 21 49 Sulfonylurea 17 40 Glitizone 15 35 None 1 2 Antihypertensive medications 0 10 23 1 8 19 2 14 32 >2 11 26 Other medications Statin 32 74 Ezetimibe 7 16 Other lipid types 2 5 No lipid meds 9 21 ACE/ARB 28 65 - Tabel 2.
Percentage of Patients Achieving All ODC Goals Per Quarter (n = 7000 for medical group, varying for DHK)
Patient Group 2004 2005 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 n 70 63 69 67 56 55 62 70 DHK 5.7 11.1 8.7 13.4 26.8 25.5 33.9 42.9 Medical group 4.2 5.8 7.4 8.6 10.7 11.2 12.0 12.1 P .53 .07 .68 .16 .0001 .0009 <.0001 <.0001 - Table 3.
Percentage of DHK's Patients Achieving Each Component of ODC Goals (n = 70 in both quarters)
Quarter LDL <100 A1c <7 BP <130 Daily ASA Tobacco Free 1 in 2004 46 53 71 59 56 4 in 2005 75 50 83 96 91 P .0008 0.72 0.11 <.0001 <.0001 ODC, optimal diabetes control; LDL, low-density lipoproteins; BP, blood pressure.
- Table 4.
Percentage of DHK's Patients Who Were Present Throughout the Study, Who Achieved ODC Goals (n = 43)
Quarter LDL <100 A1c <7 BP <130 Daily ASA Tobacco Free All 5 1 in 2004 42 46 65 56 56 2 4 in 2005 79 54 84 100 91 46 P .0006 .37 .045 <.0001 .0001 <.0001 ODC, optimal diabetes control; LDL, low-density lipoproteins; BP, blood pressure.
- Table 5.
Mean Values* for DHK's Patients Who Were Lost or Added to His Care (at the time of departure or arrival)
Group n LDL A1c BP Age Lost 27 98 (2)† 6.8 (4) 120 62 years Added 27 91 (3) 7.7 118 59 years P .46 .053 .75 .25 * ASA and tobacco not included because status not well documented in 2004 for some of these patients.
† Numbers in parentheses are for the number of patients with no measure available.
